CellSight Technologies Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2M

  • Investors
  • 4

CellSight Technologies General Information

Description

Developer of molecular imaging equipment designed to treat cancer. The company's platform helps in images activated T cells and scans early in the treatment cycle to determine whether a patient's immune system is responding appropriately to their immunotherapy regimen, enabling oncologists to ensure appropriate immune response for patients increasing immunotherapy efficacy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • 185 Berry Street
  • Suite 350
  • San Francisco, CA 94107
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellSight Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 01-Jan-2022 $2M Completed Clinical Trials - General
6. Grant 01-Jan-2019 00000 Completed Clinical Trials - General
5. Grant 01-Jan-2018 00000 Completed Clinical Trials - General
4. Grant 21-Sep-2017 00.000 Completed Clinical Trials - General
3. Accelerator/Incubator 01-Jan-2016 Completed Clinical Trials - General
2. Grant 01-Jan-2013 $1.75M Completed Clinical Trials - General
1. Accelerator/Incubator Completed Clinical Trials - General
To view CellSight Technologies’s complete valuation and funding history, request access »

CellSight Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular imaging equipment designed to treat cancer. The company's platform helps in images activated T ce
Diagnostic Equipment
San Francisco, CA
5 As of 2023
0000000000

000000

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupta
0000000000 000000000
Wichita, KS
0 As of 0000
00.00
00000000000 00.00

0000 0

lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000 000000000
Oxford, United Kingdom
00 As of 0000
000.00
00000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CellSight Technologies Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeoTherma Oncology Venture Capital-Backed Wichita, KS 0 00.00 00000000000 00.00
Blue Earth Diagnostics Formerly VC-backed Oxford, United Kingdom 00 000.00 000000&0 000.00
Linnaeus Therapeutics Venture Capital-Backed Haddonfield, NJ 0 000.00 00000000000 000.00
Navidea Biopharmaceuticals Corporation Dublin, OH 00 000.00 0000000000.
MTTI (Pennsylvania) Corporation West Chester, PA 0000000000
You’re viewing 5 of 16 competitors. Get the full list »

CellSight Technologies Executive Team (5)

Name Title Board Seat Contact Info
Aruna Gambhir Chief Executive Officer
Samuel Quezada Co-Founder & Chief Operating Officer
Jelena Levi Ph.D Chief Scientific Officer
You’re viewing 3 of 5 executive team members. Get the full list »

CellSight Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellSight Technologies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
QB3 Accelerator/Incubator 000 0000 000000 0
To view CellSight Technologies’s complete investors history, request access »

CellSight Technologies FAQs

  • When was CellSight Technologies founded?

    CellSight Technologies was founded in 2009.

  • Who is the founder of CellSight Technologies?

    Samuel Quezada, Shahriar Yaghoubi Ph.D, and Sanjiv Gambhir Ph.D are the founders of CellSight Technologies.

  • Who is the CEO of CellSight Technologies?

    Aruna Gambhir is the CEO of CellSight Technologies.

  • Where is CellSight Technologies headquartered?

    CellSight Technologies is headquartered in San Francisco, CA.

  • What is the size of CellSight Technologies?

    CellSight Technologies has 5 total employees.

  • What industry is CellSight Technologies in?

    CellSight Technologies’s primary industry is Diagnostic Equipment.

  • Is CellSight Technologies a private or public company?

    CellSight Technologies is a Private company.

  • What is CellSight Technologies’s current revenue?

    The current revenue for CellSight Technologies is 000000.

  • Who are CellSight Technologies’s investors?

    National Institutes of Health, Springboard Enterprises, National Cancer Institute, and QB3 have invested in CellSight Technologies.

  • Who are CellSight Technologies’s competitors?

    NeoTherma Oncology, Blue Earth Diagnostics, Linnaeus Therapeutics, Navidea Biopharmaceuticals, and MTTI (Pennsylvania) are some of the 16 competitors of CellSight Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »